000220 — Yuyu Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Market Cap
KR₩76bn
Enterprise Value
KR₩80bn
Revenue
KR₩133bn

Annual balance sheet for Yuyu Pharma, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	20,615	50,263	30,778	32,354	41,832
Net Total Accounts Receivable
Net Total Receivables	20,004	22,793	24,816	24,455	19,731
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	64,467	98,888	96,358	101,597	101,947
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	78,073	80,341	81,371	81,403	89,987
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	154,901	192,985	195,205	198,214	207,687
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	18,399	30,015	64,316	49,975	64,480
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	40,542	68,704	78,389	86,026	82,455
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	114,359	124,281	116,816	112,188	125,232
Total Liabilities & Shareholders' Equity	154,901	192,985	195,205	198,214	207,687
Total Common Shares Outstanding
Total Preferred Shares Outstanding